| ElectroMotive drug administration (EMDA) of Mitomycin C as first-line salvage therapy in high risk “BCG failure” non muscle invasive bladder cancer: 3 years follow-up outcomes M Racioppi, L Di Gianfrancesco, M Ragonese, G Palermo, E Sacco, ... BMC cancer 18, 1-9, 2018 | 78 | 2018 |
| Can Neutrophil-to-Lymphocyte ratio predict the response to BCG in high-risk non muscle invasive bladder cancer? M Racioppi, LD Gianfrancesco, M Ragonese, G Palermo, E Sacco, ... International braz j urol 45, 315-324, 2019 | 33 | 2019 |
| The impact of COVID-19 outbreak on urolithiasis emergency department admissions, hospitalizations and clinical management in central Italy: a multicentric analysis M Antonucci, SM Recupero, V Marzio, M De Dominicis, F Pinto, N Foschi, ... Actas Urológicas Españolas (English Edition) 44 (9), 611-616, 2020 | 27 | 2020 |
| Mechanisms of resistance to second-generation antiandrogen therapy for prostate cancer: actual knowledge and perspectives F Pinto, F Dibitetto, M Ragonese, P Bassi Medical Sciences 10 (2), 25, 2022 | 26 | 2022 |
| Implementation of frailty preoperative assessment to predict outcome in patients undergoing urological surgery: a systematic review and meta‐analysis P Aceto, P Bassi, L Sollazzi, M Racioppi, G Fortunato, L Di Gianfrancesco, ... BJU international 127 (5), 507-517, 2021 | 25 | 2021 |
| Postoperative quality of life in patients with ileal neobladder at short-, intermediate-and long-term follow-up D D'agostino, M Racioppi, D Pugliese, M Ragonese, L Di Gianfrancesco, ... Urologia internationalis 97 (1), 54-60, 2016 | 23 | 2016 |
| The bladder epicheck test and cytology in the follow-up of patients with non-muscle-invasive high grade bladder carcinoma. F Pierconti, M Martini, T Cenci, V Fiorentino, L Di Gianfrancesco, ... Urologic Oncology: Seminars and Original Investigations 40 (3), 108. e19-108 …, 2022 | 20 | 2022 |
| Improved non-invasive diagnosis of bladder cancer with an electronic nose: a large pilot study PF Bassi, L Di Gianfrancesco, L Salmaso, M Ragonese, G Palermo, ... Journal of Clinical Medicine 10 (21), 4984, 2021 | 20 | 2021 |
| Chemoablation with intensive intravesical mitomycin C treatment: a new approach for non–muscle-invasive bladder cancer M Racioppi, L Di Gianfrancesco, M Ragonese, G Palermo, E Sacco, ... European Urology Oncology 2 (5), 576-583, 2019 | 19 | 2019 |
| An Italian multicenter analysis of emergency admissions and treatment of upper tract urolithiasis during the lockdown and reopening phases of the COVID‐19 pandemic: Are we … D Castellani, M Ragonese, M Di Rosa, V Marzio, L Di Gianfrancesco, ... International Journal of Urology 28 (9), 950-954, 2021 | 17 | 2021 |
| Is Systemic Immune-Inflammation Index a Real Non-Invasive Biomarker to Predict Oncological Outcomes in Patients Eligible for Radical Cystectomy? P Russo, F Marino, F Rossi, FP Bizzarri, M Ragonese, F Dibitetto, ... Medicina 59 (12), 2063, 2023 | 16 | 2023 |
| The challenges of Bacillus of Calmette-Guerin (BCG) therapy for high risk non muscle invasive bladder cancer treatment in older patients M Racioppi, L Di Gianfrancesco, M Ragonese, G Palermo, E Sacco, ... Journal of geriatric oncology 9 (5), 507-512, 2018 | 15 | 2018 |
| El impacto de la COVID-19 en las admisiones al servicio de urgencias, hospitalizaciones y manejo clínico de la urolitiasis en el centro de Italia: análisis multicéntrico M Antonucci, SM Recupero, V Marzio, M De Dominicis, F Pinto, N Foschi, ... Actas Urológicas Españolas 44 (9), 611-616, 2020 | 12 | 2020 |
| The role of bladder Epicheck test in follow-up of patients with non-muscle invasive bladder cancer M Ragonese, L Di Gianfrancesco, G Palermo, F Pierconti, M Martini, ... Clinical Genitourinary Cancer 20 (4), e271-e275, 2022 | 11 | 2022 |
| Mitomycin C: new strategies to improve efficacy of a well-known therapy M Ragonese, M Racioppi, PF Bassi, L Di Gianfrancesco, N Lenci, ... Urologia Journal 83 (2_suppl), 24-28, 2016 | 11 | 2016 |
| Second-Line Conservative Device-Assisted Intravesical Treatment in Selected Patients With Recurrent High-Risk Non–Muscle-Invasive Bladder Cancer L Di Gianfrancesco, M Ragonese, G Palermo, E Sacco, PF Bassi, ... Clinical Genitourinary Cancer 19 (2), e100-e119, 2021 | 10 | 2021 |
| Perioperative Outcomes of Robotic Radical Prostatectomy with Hugo™ RAS versus daVinci Surgical Platform: Propensity Score-Matched Comparative Analysis C Gandi, F Marino, A Totaro, E Scarciglia, F Bellavia, R Bientinesi, F Gavi, ... Journal of Clinical Medicine 13 (11), 3157, 2024 | 9 | 2024 |
| Robot-Assisted Radical Prostatectomy Performed with the Novel Hugo™ RAS System: A Systematic Review and Pooled Analysis of Surgical, Oncological, and Functional Outcomes F Marino, S Moretto, F Rossi, C Gandi, F Gavi, R Bientinesi, M Campetella, ... Journal of Clinical Medicine 13 (9), 2551, 2024 | 9 | 2024 |
| Robot-Assisted Radical Prostatectomy Performed with the Novel Surgical Robotic Platform Hugo™ RAS: Monocentric First Series of 132 Cases Reporting Surgical, and Early … A Totaro, E Scarciglia, F Marino, M Campetella, C Gandi, M Ragonese, ... Cancers 16 (8), 1602, 2024 | 9 | 2024 |
| What can the metaverse do for urology? C Gandi, L Cosenza, M Campetella, F Marino, M Ragonese, R Bientinesi, ... Urologia Journal 90 (3), 454-458, 2023 | 9 | 2023 |
